Use of Automated Office Blood Pressure Monitoring

May 24, 2022 updated by: Tonya Breaux-Shropshire, University of Alabama at Birmingham

Use of Automated Office Blood Pressure Monitoring in Older Working-age Adults

Blood pressure measurements by three methods Office Blood Pressure Measurement (OBPM), Automated Office Blood Pressure Measurement (AOBPM), and Home Blood Pressure Measurement (HBPM) were collected retrospectively across three visits for patients (N=28) referred to a specialty hypertension (HTN) clinic. Demographic data were analyzed using summary statistics. The differences between AOBPM, HBPM, and OBPM were examined using mixed models repeated measures analysis for time and method for each visit.

Study Overview

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35294
        • University of Alabama at Birmingham

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 19 years and older
  • Uncontrolled BP
  • Prescribed three or more antihypertensive medications at the time of referral
  • Higher risk for poor CV outcomes than patients with essential HTN
  • OBPM systolic BP of greater than 140 mmHg and diastolic BP of greater than or equal to 90 mm Hg upon initial clinic assessment.

Exclusion Criteria:

  • Less than 19 years old
  • Had a systolic BP of less than 140 mm Hg and diastolic BP of less than 90 mmHg upon initial clinic assessment.
  • Also, patients on less than three antihypertensive medications, with less than three visits, and who have controlled OBPM were excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SCREENING
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Office Blood Pressure Measurement (OBPM)
Traditional office blood pressure monitoring in the primary care clinical environment.
The use of three different devices: traditional office blood pressure measurement cuff (OBPM), automated office blood pressure measurement cuff (AOBPM), and home blood pressure measurement cuff (HBPM).
EXPERIMENTAL: Automated Office Blood Pressure Measurement (AOBPM)
Blood pressure measurement using a validated BpTRU device
The use of three different devices: traditional office blood pressure measurement cuff (OBPM), automated office blood pressure measurement cuff (AOBPM), and home blood pressure measurement cuff (HBPM).
EXPERIMENTAL: Home Blood Pressure Measurement (HBPM)
Blood pressure measurement at patient's home using home monitoring device.
The use of three different devices: traditional office blood pressure measurement cuff (OBPM), automated office blood pressure measurement cuff (AOBPM), and home blood pressure measurement cuff (HBPM).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants using Traditional office blood pressure measurement (OBPM)
Time Frame: Baseline
Blood pressure control: Traditional office blood pressure measurement less than 140/90 mm Hg
Baseline
Number of participants using Traditional office blood pressure measurement (OBPM)
Time Frame: Up to 8 weeks
Blood pressure control: Traditional office blood pressure measurement less than 140/90 mm Hg
Up to 8 weeks
Number of participants using Traditional office blood pressure measurement (OBPM)
Time Frame: Up to 16 weeks
Blood pressure control: Traditional office blood pressure measurement less than 140/90 mm Hg
Up to 16 weeks
Number of participants using Automated office blood pressure measurement (AOBPM)
Time Frame: Baseline
Blood pressure control: Automated office blood pressure measurement less than 130/80 mm Hg
Baseline
Number of participants using Automated office blood pressure measurement (AOBPM)
Time Frame: Up to 8 weeks
Blood pressure control: Automated office blood pressure measurement less than 130/80 mm Hg
Up to 8 weeks
Number of participants using Automated office blood pressure measurement (AOBPM)
Time Frame: Up to 16 weeks
Blood pressure control: Automated office blood pressure measurement less than 130/80 mm Hg
Up to 16 weeks
Number of participants using Home blood pressure measurement (HBPM)
Time Frame: Baseline
Blood pressure control: Home blood pressure measurement less than 130/80 mm Hg
Baseline
Number of participants using Home blood pressure measurement (HBPM)
Time Frame: Up to 8 weeks
Blood pressure control: Home blood pressure measurement less than 130/80 mm Hg
Up to 8 weeks
Number of participants using Home blood pressure measurement (HBPM)
Time Frame: Up to 16 weeks
Blood pressure control: Home blood pressure measurement less than 130/80 mm Hg
Up to 16 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 5, 2021

Primary Completion (ACTUAL)

July 5, 2021

Study Completion (ACTUAL)

July 5, 2021

Study Registration Dates

First Submitted

April 19, 2022

First Submitted That Met QC Criteria

May 24, 2022

First Posted (ACTUAL)

May 27, 2022

Study Record Updates

Last Update Posted (ACTUAL)

May 27, 2022

Last Update Submitted That Met QC Criteria

May 24, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • IRB-300006396

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Blood pressure measurement device

3
Subscribe